Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 718 across all filing types
Latest filing 2026-03-19 Audit Report / Informat…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
감사보고서제출(자회사의 주요경영사항)
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides the audit opinion, financial highlights (consolidated and separate), and details regarding the external auditor. While it contains financial data, it is a standard regulatory disclosure announcement regarding the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it fits the 'Regulatory Filings' category. FY 2025
2026-03-19 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal regulatory filing titled '주주총회소집결의' (Resolution for Convening a General Meeting of Shareholders) and includes a '정정신고' (Correction Report). It details the agenda for an upcoming Annual General Meeting (AGM), including financial statement approval, director appointments, and capital reduction plans. Since this document provides the specific agenda, meeting details, and director candidate information for an upcoming shareholder meeting, it falls under the category of Proxy Solicitation & Information Statement (PSI), which is used for materials requesting votes and providing meeting information to shareholders.
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Aprogen Inc. It contains the meeting date, location, agenda items (including financial statement approval, director appointments, and capital reduction), and detailed management reference materials (사외이사 활동내역, 최대주주 거래내역, 사업 개요). This is a standard proxy statement/notice package sent to shareholders to inform them of the upcoming AGM and solicit their votes. In the context of the provided filing types, this document is best classified as a Proxy Solicitation & Information Statement (PSI).
2026-03-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동(자회사의 주요경영사항)
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Aprogen) announcing a significant change (over 15%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for reporting preliminary financial results or material changes before the final audit report is finalized. Since it provides specific financial highlights and performance metrics rather than just an announcement of a report's availability, it falls under the Earnings Release (ER) category. FY 2025
2026-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경(자회사의 주요경영사항)
Management Reports Classification · 1% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding a significant change in financial structure (30% or more change in revenue or profit/loss). This is a standard disclosure requirement in the Korean stock market (KRX) for reporting preliminary financial results before the final audit report is filed. Since it provides key financial highlights and performance metrics for the fiscal year, it falls under the 'Earnings Release' category.
2026-02-27 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) system regarding a 'Single Sales/Supply Contract' amendment (correction report). It details a change in the contract end date for a supply agreement with POSCO. Since this is a specific regulatory disclosure of a material contract event that does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2026-02-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.